Overproduction of the Extracellular Lipase Is Closely Related to That of Metalloprotease in Serratia marcescens
スポンサーリンク
概要
- 論文の詳細を見る
The recombinant strain of Serratia marcescens Sr41 carrying the lipA gene encoding the extracellular lipase on a high-copy-number plasmid, pUC19,overproduced lipase. The extracellular lipase activity of the hyperproducing strain reached 220,000U/ml of the culture medium and was about 9-fold greater than that of the strain carrying pUC19. The extracellular protease activity of the lipase-hyperproducing recombinant strain was decreased by 90% compared with that of the strain carrying pUC19. Sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis revealed overproduction of the lipase and reduction of the extracellular metalloprotease production in the culture medium of the lipase-hyperproducing strain. The production of extracellular metal-loprotease was impaired by the increase of lipA gene expression. Thus, construction of the lipase-hyper-producing strain which reduced extracellular metalloprotease production, was achieved by self-cloning of the lipA gene in S. marcescens. The mutants carrying the metalloprotease gene defects constructed by homologous recombination showed significantly elevated extracellular lipase activity. These results suggested that the production of extracellular lipase was closely related to the metalloprotease production and that the secretion of the two proteins may be competitive in S. marcescens.
- 公益社団法人日本生物工学会の論文
- 1996-02-25
著者
-
Shibatani T
Tanabe Seiyaku Co. Ltd. Osaka Jpn
-
Shibatani Takeji
Product Technology Development Laboratory Tanabe Seiyaku Co.ltd.
-
Shibatani Takeji
Pharmaceutical Developemnt Research Laboratory:tanabe Seiyaku Co. Ltd.
-
KOMATSUBARA Saburo
Lead Generation Research Laboratory at Toda, Tanabe Seiyaku Co., Lid.
-
Komatsubara Saburo
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Komatsubara Saburo
Discovery Research Laboratory
-
OMORI Kenji
Lead Generation Research Laboratory at Kashima, Tanabe Seiyaku Co., Ltd.
-
Kawai Eri
Discovery Research Laboratory Tanabe Seiyaku Co.ltd.
-
AKATSUKA HIROYUKI
Discovery Research Laboratory, Tanabe Seiyaku Co.Ltd.
-
AKATSUKA HIROYUKI
Lead Generation Research Laboratory
-
KAWAI ERI
Lead Generation Research Laboratory
-
Akatsuka Hiroyuki
Discovery Research Laboratory Tanabe Seiyaku Co.ltd.
関連論文
- Optical Resolution of a 1,5-Benzothiazepine Derivative, a Synthetic Intermediate of Diltiazem, by Preferential Crystallization and Diastereomeric Salt Formation
- Expression of the Xylan-Degrading Genes of Bacillus pumilus IPO in Saccharomyces cerevisiae
- Aurantiamide Acetate, a Selective Cathepsin Inhibitor, Produced by Aspergillus penicilloides
- TMC-52A to D, Novel Cysteine Proteinase Inhibitors, Produced by Gliocladium sp.
- 408 The Role of Asp21 of the Xylanase from Bacillus pumilus IPO
- Purification and Some Properties of Alanine Aminotransferase from Candida maltosa
- TMC-66, a New Endothelin Converting Enzyme Inhibitor Produced by Streptomyces sp. A5008
- TMC-49A, a Novel Transcriptional Up-Regulator of Low Density Lipoprotein Receptor, Produced by Streptomyces sp. AS1345
- Trichostain A and Herboxidiene Up-regulate the Gene Expression of Low Density Lipoprotein Receptor
- Boromycin, an Anti-HIV Antibiotic
- TMC-69, a New Antitumor Antibiotic with Cdc25A Inhibitory Activity, Produced by Chrysosporium sp. TC1068 : Taxonomy, Fermentation and Biological Activities
- Selective Isolation and Distribution of Actinomadura rugatobispora Strains in Soil
- Biosynthesis of the Fungal Polyketide Antibiotics TMC-151s : Origin of the Carbon Skeleton
- TMC-89A and B, New Proteasome Inhibitors from Streptomyces sp. TC 1087
- TMC-135A and B, New Triene-ansamycins, Produced by Streptomyces sp.
- Production of TMC-151, TMC-154 and TMC-171, a new class of antibiotics, is specific to 'Gliocladium roseum' group
- TMC-95A, B, C, and D, Novel Proteasome Inhibitors Produced by Apiospora montagnei Sacc. TC 1093 Taxonomy, Production, Isolation, and Biological Activities
- TMC-86A, B and TMC-96, New Proteasome Inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094 : II. Physico-chemical Properties and Structure Determination
- TMC-171A, B, C and TMC-154, Novel Polyketide Antibiotics Produced by Gliocladium sp. TC 1304 and TC 1282
- TMC-86A, B and TMC-96, New Proteasome Ihibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094 I. Taxonomy, Fermentation, Isolation, and Biological Activities
- Production, Isolation and biological Properties of TMC-120A, B and C, Novel Inhibitors of Eosinophil Survival from Aspergillus ustus TC 1118
- TMC-169, a New Antibioctic of the Aspochalasin Group Produced by Aspergillus flavipes
- TMC-2A, -2B and -2C, Novel Dipeptidyl Peptidase IV Inhibitors Produced by Aspergillus oryzae A374 I. Taxonomy of Producing Strain, Fermentation, and Biochemical Properties
- The Structures of Sulfomycins II and III
- Microbial Asymmetric Reduction of (RS)-2-(4-Methoxyphenyl)-1,5-benzothiazepin-3,4(2H, 5H)-dione, the Key Intermediate in the Synthesis of Diltiazem Hydrochloride
- Production of Optically Active 3-Phenylglycidic Acid Ester by the Lipase from Serratia marcescens on a Hollow-Fiber Membrane Reactor
- TMC-2A, -2B and -2C, New Dipeptidyl Peptidase IV Inhibitors Produced by Aspergillus oryzae A374 II. Isolation and Structure Determination
- TMC-1 A, B, C and D, New Antibiotics of the Manumycin Group Produced by Streptomyces sp. Taxonomy, Production, Isolation, Physico-chemical Properties, Structure Elucidation and Biological Properties
- Preparation of (2S, 3S)-2,3-Dihydro-3-Hydroxy-2-(4-Methoxyphenyl)-1,5-Benzothiazepin4-(5H)-One by Microbial Conversion
- Production of (2S, 3S)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one, a Key Intermediate for Diltiazem Synthesis, by Bakers' Yeast-Mediated Reduction
- Isolation and Analysis of Lipase-Overproducing Mutants of Serratia marcescens
- Overproduction of the Extracellular Lipase Is Closely Related to That of Metalloprotease in Serratia marcescens
- Lipase-Catalyzed Asymmetric Hydrolysis of 3-Phenylglycidic Acid Ester, the Key Intermediate in the Synthesis of Diltiazem Hydrochloride
- TMC-34, a New Macrolide Antifungal Antibiotic
- A Membrane Bioreactor Combined with Crystallizer for Production of Optically Active (2R, 3S)-3-(4-Methoxyphenyl)-Glycidic Acid Methyl Ester